MiMedx Reports Positive Clinical Trial Results of AmnioFix for Plantar Fasciitis

On March 26, MiMedx Group, Inc. (MDXG) reported positive results from its Phase 2B IND clinical trial of AmnioFix. In the clinical trial, patients who received the AmnioFix Injectable treatment for their Plantar Fasciitis had a clinically and statistically significant improvement when compared to the control group. Plantar Fasciitis is the most common cause of […]

Read more...

Scientific Games Awarded New Contract From Arizona Lottery

Scientific Games Corporation (SGMS) announced on March 7 that the company received a new contract from the Arizona Lottery. The contract will last for five years, and Scientific Games will provide administrative systems technology for the Arizona Lottery’s headquarters in Phoenix. The new administrative systems will be integrated with the advanced gaming and retail technology […]

Read more...

Comtech Receives $123.6 Million Contract from U.S. Army

On March 5, Comtech Telecommunications Corp. (CMTL) announced that its Command and Control Technologies group received a three-year contract from the U.S. Army worth $123.6 million. Under the contract, Comtech will provide ongoing sustainment services for the AN/TSC-198A SNAP (Secret and Non-classified Internet Protocol Router Access Point), Very Small Aperture Terminals. SNAP terminals provide quick, […]

Read more...

Park Hotels and Resorts Announces Secondary Stock Offering and Stock Repurchase

Park Hotels and Resorts Inc. (PK) announced on March 5 that HNA HLT Holdco LLC, the Selling Stockholder, would carry out an underwritten secondary offering of 32,950,000 shares of Park’s common stock. The Selling Stockholder has granted the underwriters the option to purchase up to 4,942,500 additional shares of stock from them. In addition, the […]

Read more...

G1 Therapeutics Reports Positive Clinical Trial Results in Patients Receiving Chemotherapy for Small Cell Lung Cancer

On March 5, G1 Therapeutics, Inc. (GTHX) reported positive topline data from its Phase 2a trial for Trilaciclib in patients receiving chemotherapy for first-line small cell lung cancer. The data from the trial showed clear evidence that Trilaciclib preserved bone marrow and immune system function from damage due to chemotherapy treatment. Trilaciclib would be the […]

Read more...

CPI Antenna Systems Division to Buy Antenna Division of Viasat

On March 12, Communications and Power Industries LLC (CPI) announced that its Antenna Systems Division signed an agreement to purchase the limited-motion satellite antenna division of Viasat, Inc. (VSAT). By selling its antenna systems division, Viasat will be able to focus more on its core business of antenna and communications technologies for broadband markets. The […]

Read more...

FDA Accepts Jazz Pharmaceuticals’ NDA for Solriamfetol Treatment in Patients with Narcolepsy and Sleep Apnea

On March 2, Jazz Pharmaceuticals plc (JAZZ) announced that the FDA has accepted the company’s filing of a New Drug Application (NDA) with standard review for market approval of Solriamfetol. The drug is an investigational medicine used for the treatment of excessive sleepiness in patients with narcolepsy and obstructive sleep apnea (OSA). The company hopes […]

Read more...

FBL Financial Makes Dividend Announcement and Authorizes New Stock Repurchase Program

On March 1, FBL Financial Group, Inc. (FFG) made some big announcements to shareholders. The company increased its quarterly dividend by 4.5% to $0.46 per share. Shareholders will receive this dividend in March along with a special cash dividend of $1.50 per share. In addition, the Board of Directors authorized a new stock repurchase program […]

Read more...